South Korea's biophotonics market is projected to grow from USD 5.0 billion in 2026 to USD 7.1 billion by 2031, representing a 7.0% compound annual growth rate, according to a ResearchAndMarkets.com report. Expansion is supported by demand for precision medicine, non-invasive diagnostics, high-resolution imaging and early disease detection across healthcare, biomedical research, drug discovery and life sciences. South Korea's semiconductor and electronics manufacturing base, advanced healthcare infrastructure and biomedical research ecosystem support domestic biophotonics innovation and supply-chain development. Imaging technologies and medical diagnostics are prominent market segments, while spectroscopy, light-based therapeutics, biosensors and bioassays also contribute to demand. Growth drivers include the rising prevalence of cancer, neurodegenerative conditions and other chronic diseases, government investment in biomedical research and healthcare innovation, and the integration of artificial intelligence into optical imaging. High capital costs, reliance on international suppliers for certain components, supply-chain uncertainty and strict safety, quality and performance requirements remain constraints. The report covers historical data from 2021 to 2025, forecasts from 2026 to 2031, market segmentation, competitive strategies, regulation, supply chains and strategic opportunities.